Psychedelics not yet ready for clinical use in ADHD treatment, study finds
In recent years, there has been growing interest among adults with ADHD in the practice of microdosing classic psychedelics such as psilocybin and LSD. The internet is full of personal accounts describing improved concentration, better impulse control and enhanced well-being. However, a recent review conducted by researchers from Wroclaw Medical University shows that the currently available scientific evidence does not allow the effectiveness of psychedelics in treating ADHD to be confirmed. This is an area of intensive research, but not a therapy ready for clinical practice.
Other Articles in this Edition
Study Suggests No Link Between Prenatal Tylenol and Risks for Autism, ADHD
Slow Maternal Response Time Linked to ADHD in Kids
Five common medications that make it harder to cope in a heatwave
How Can I Explain My Adult ADHD to People I Know?
Genetic markers for ADHD influence early toddler activity levels
Exploring Canine-Assisted Interactions for Children with ADHD
Student-led research explores how music affects learning for students with ADHD
Psychedelics not yet ready for clinical use in ADHD treatment, study finds
Student with ADHD and autism proves what’s possible with the right support
New Phase 3 Post Hoc Analyses of Centanafadine for the Treatment of Adults With ADHD